who should not use tirzepatide Users of Zepbound or Mounjaro Had Lower Blood Pressure in Study Tirzepatide vs. Semaglutide for Weight

These results include data from patients using both FDA-approved and compounded formulations

Its modestly effective: weight loss up to 3-6% of total body weight is a significant result for many patients Less effective compared to new GLP-1 products: Mounjaro/Zepbound, Wegovy, and Ozempic lead to more weight loss Its not the most effective treatment for obesity: in case of bariatric surgery, weight loss will be 60-80% excess weight reduction, more effective by orders of magnitude compared to medications Lifelong drug therapy: otherwise youll regain your lost weight Trulicity might be a suitable weight loss product for patients with BMI less than 30 who need to lose 10-20 pounds

Dermal tissue concentration will be lower because the peptide enters systemic circulation immediately rather than diffusing laterally into nearby fibroblasts first

Perez, R

If youre interested in exploring options, our GLP-1 app can help guide your weight management journey

doi:10.2337/diabetes.52.5.1147 197